Latest News

 Filter by Provider

Shorter-duration structured finance deals are reshaping the insurer's business mix.

NerdWallet's sales grew in Q3. Its costs just rose a whole lot more.

Micron is bouncing back after Thursday’s chip rout, but the reason it fell- a possible slowdown in data center construction- hasn’t gone away.

Predictable subscription cash flows underpin a new $60 million special dividend.

Digital growth outpaced the core as full-year guidance moved higher.

Management eyes nonaccrual resolutions and office exits to redeploy capital

Some companies will perform pretty well regardless of whether or not interest rates rise.

Opendoor is selling more and buying a lot more homes, but margins are shrinking, losses are widening, and its year-end profit goal is now behind schedule.

Taiwan Semiconductor is a top option in the AI investment space.

European expansion and Canadian brand strength drove a record quarter.

Management details its data center power push and expanding Cedar LNG progress.

Midweek business travel and margin gains lifted results, prompting higher guidance.

Production jumped 20% as Baobab resumed and free cash flow nears.

Record quarterly EBITDA is paired with a major asset sale and a new acquisition.

There's a big factor you need to address.

Oklo’s stock is jumping after earnings, but the company is basically pre-revenue, and its first plant is still years from coming online.

Humana's Star rating gains and new BlackRock partnership shape its 2027 margin outlook.

Wholesale gains offset softer retail fuel volumes in a strong quarter.

Capital recycling and AI expansion drove a 10% funds-from-operations gain.

Record cash flow offset by rising input costs and a sharply lower outlook

At 67, you've hit full retirement age--here's what the typical monthly check looks like.

Lift truck and material handling solutions manufacturer Hyster-Yale Materials Handling (NYSE:HY) fell short of the market’s revenue expectations in Q3 2026, ...

Nine-month capital spending hit $412.8 million on the way to its annual goal.

Leadership changed hands as Concentra weighs entry into a new state.

REGENXBIO (NASDAQ:RGNX) is approaching pivotal trial results for its eye disease gene therapy and preparing a U.S. application for its Duchenne muscular dystrophy treatment, executives said during the company’s third-quarter earnings call. The company and partner AbbVie expect top-line results this

U.S. Bancorp (NYSE:USB) expects to restart share repurchases promptly after pausing them in the previous quarter, as it works to build capital and expand its capital markets business following the acquisition of BTIG, executives said at a conference. Chief Financial Officer John Stern said the bank

Beauty Health (NASDAQ:SKIN), referred to as SkinHealth Systems on its earnings call, reported a narrower revenue decline and higher adjusted earnings for the third quarter of 2026, as growth in consumables helped offset weaker equipment sales. Revenue fell 2.1% from a year earlier to $69.2 million,

Skyward Specialty Insurance Group (NASDAQ:SKWD) reported higher operating earnings and premium growth for the third quarter of 2026, even as executives described increasing competition in parts of the property and casualty insurance markets. Operating income rose to $58 million, or $1.28 per dilute

Informa TechTarget (NASDAQ:TTGT) lowered its full-year 2026 outlook after reporting a decline in third-quarter revenue, as customers took longer to commit to spending and a healthy sales pipeline converted more slowly than management expected. The company now expects full-year revenue to be modestl

Regency Centers (NASDAQ:REG) raised its full-year outlook after reporting stronger third-quarter property income and record leasing levels, while executives said growth in 2027 could moderate as occupancy gains slow and debt refinancing adds pressure to earnings. Same-property net operating income,

Assured Guaranty (NYSE:AGO) expects financial guaranty production to exceed $400 million in 2026, after growth across its business lines helped lift production 44% in the first nine months of the year. The company reported third-quarter adjusted operating income of $86 million, or $1.94 per share,

WillScot (NASDAQ:WSC) reported higher third-quarter revenue and raised its 2026 sales outlook as demand for modular space helped reverse a decline in units on rent. The company also offered an initial forecast for organic growth in 2027, while cautioning that the pace of future data center construct

Nutex Health (NASDAQ:NUTX) reported lower third-quarter revenue and earnings despite a rise in hospital visits, as executives pointed to prior-year revenue adjustments tied to collections under the federal independent dispute resolution process. Revenue fell to $217.6 million in the third quarter o

E.W. Scripps (NASDAQ:SSP) reported a third-quarter profit as record midterm political advertising boosted its local television business, and executives said they plan to use election-related cash to reduce debt. The company recorded $284 million in full-year Local Media political advertising revenu

Carlyle Secured Lending (NASDAQ:CGBD) reported third-quarter 2026 net investment income of $0.36 per share, covering its $0.35 base dividend, as higher income from joint ventures helped offset a smaller average loan portfolio. Net asset value rose to $15.65 per share as of Sept. 30 from $15.61 at t

Record awards and a $34.3 billion backlog meet a new round of cost pressure.

Moderna stock surged to a five-year high Friday on the back of its Street-walloping vaccine sales and guidance hike for the year.

Conversions slowed, but AI tools are pulling sellers deeper into the platform.

Political ad windfall masked softness in core advertising and networks.

Focal One sales grew, but deal timing pushed some placements into Q4.

Margins slipped on supply strain, but Plato and GRIN milestones stayed on track.

There's a missing piece of the puzzle that can't be overlooked.

NuScale Power signed an agreement to secure key nuclear reactor components. Could a major deal be on the horizon?

Customer inventory cuts hit Vafseo sales as a reimbursement cliff nears.

Restructuring reshapes the company around its experiences business.

Thursday was the Nasdaq's worst day since April 2025. Here's what history says often comes next and how to make a rough market work for you.

Management sees little acquisition value as oil drilling takes priority over gas.

Member tenure rose sharply as a CEO handoff approaches for 2027.